Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.
about
Multiple system atrophy: cellular and molecular pathology.Activation of PP2A-like phosphatase and modulation of tau phosphorylation accompany stress-induced apoptosis in cultured oligodendrocytesWidespread alterations of alpha-synuclein in multiple system atrophyWidespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.Multiple system atrophy: a sporadic synucleinopathy.The oligodendroglia cytoskeleton in health and disease.The pathogenesis of multiple system atrophy: past, present, and future.Organization and functional roles of the cytoskeleton in oligodendrocytes.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesCharacteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration?Cellular pathology in multiple system atrophy.What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?Globular glial tauopathies (GGT): consensus recommendations.Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology.Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.SUMO-1 is associated with a subset of lysosomes in glial protein aggregate diseases.MAPT haplotype diversity in multiple system atrophyMultiple system atrophy: clues from inclusions.Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease.The neuropathology of multiple system atrophy and its therapeutic implications.A case of multiple system atrophy with hyperglycinaemia due to a selective deficiency of glycine transporter mRNA.The diagnostic value of cerebrospinal fluid tau protein in dementing and nondementing neuropsychiatric disorders.
P2860
Q24535446-797282E0-8649-4B92-8C42-FA55EF04BFD4Q28578658-9328D47E-92FE-4B1E-ADC9-0AAD9A4C92A4Q30444927-636490D5-BF86-4751-A342-A061886AAA99Q33738316-7984D3AE-B986-4AAA-9089-FF3874CF501DQ33750069-A3EA609D-C09F-49A1-97F2-F275FBF6EDC1Q33829490-78DD4469-BF5B-4A58-AFB9-14285E85CF61Q34048136-9FFECE4D-8FE7-424C-BA57-0029EE4E9319Q34199602-3CAAAF71-D597-489C-AFA7-E3976F93FF9FQ34538330-C44F6A41-D999-41FE-95AF-DD56A6A0AB8AQ34658928-EC1BB59E-BCC9-418E-A0FB-9A1787A5F2DCQ34989158-73E83A05-2AB4-4BBE-97E6-7B351CB966CEQ36589164-279610B5-9D57-4270-B284-B7BD7557CF44Q37146578-904FA160-EB34-4448-816B-14C300078590Q37557601-189AC337-A637-4BB9-A6FA-EAABC9CBC04AQ38079317-A41741B5-B148-40DF-8C2D-CAEA1EA3CCC1Q38258246-63E5E328-E412-41F1-A491-591C2FE731F6Q38821003-65CFE81C-CCFC-4673-BFC3-68A8F974E462Q39064365-919C6226-5FB1-458B-8786-8C323097544AQ39228154-7445D7A3-E561-4A75-815A-0968DC6F458FQ40989131-732DD384-6A5C-4116-920E-78631F6A28B6Q42850927-807BC8CE-53F6-43D6-9B0D-A74C46C0EAA3Q43650971-1898DB96-AF64-43E3-8051-38B973D8A357Q43778565-14D4FE85-E73D-4DAD-BEE5-9EE42C0CD6D0Q45940520-AF9DD21B-0D17-4468-AD61-7CE3B9544014Q48347991-E39D610D-8B45-4DA4-8C24-597B6BF275C0Q51926890-64B5CB49-D4E8-4905-B893-7BFC17194FD4
P2860
Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Tau protein in the glial cytop ...... al tau in Alzheimer's disease.
@en
type
label
Tau protein in the glial cytop ...... al tau in Alzheimer's disease.
@en
prefLabel
Tau protein in the glial cytop ...... al tau in Alzheimer's disease.
@en
P2093
P1433
P1476
Tau protein in the glial cytop ...... mal tau in Alzheimer's disease
@en
P2093
B H Anderton
N J Cairns
P F Atkinson
P L Lantos
S E Daniel
P356
10.1016/S0304-3940(97)00474-6
P407
P577
1997-07-01T00:00:00Z